Valagro Biosciences Profile
Key Indicators
- Authorised Capital ₹ 51.50 Cr
as on 17-06-2024
- Paid Up Capital ₹ 28.86 Cr
as on 17-06-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.00 Cr
as on 17-06-2024
- Satisfied Charges ₹ 63.42 Cr
as on 17-06-2024
- Revenue 27.45%
(FY 2023)
- Profit -16.25%
(FY 2023)
- Ebitda 5.69%
(FY 2023)
- Net Worth 38.98%
(FY 2023)
- Total Assets 38.20%
(FY 2023)
About Valagro Biosciences
The Corporate was formerly known as Valagro Biosciences Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 51.50 Cr and a paid-up capital of Rs 28.86 Cr.
The company currently has active open charges totaling ₹19.00 Cr. The company has closed loans amounting to ₹63.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Valagro Biosciences Private Limited India are Sreeramakavacham Krishna as CFO and Satya Bhamidi as Company Secretary. Tokala Kumar, Rama Sreeramakavacham, Alessandro Calbucci, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC050060
- Company No.
050060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2006
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Valagro Biosciences Private Limited offer?
Valagro Biosciences Private Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training, Fertilizers and Soil Additives, Plant Growth Promoters, Plant Nutrient, Nitrogen Fertilizers, NPK Fertilizer, Fertilizer, Micronutrient, Crop Yield Booster.
Who are the key members and board of directors at Valagro Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreeramakavacham Krishna  | CFO | 25-Jul-2017 | Current |
| Satya Bhamidi | Company Secretary | 01-Sep-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tokala Kumar | Whole-Time Director | 10-Dec-2018 | Current |
| Rama Sreeramakavacham | Whole-Time Director and Cfo | 18-Sep-2023 | Current |
Alessandro Calbucci  | Director | 08-Mar-2021 | Current |
| Fornara Luca | Director | 25-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Valagro Biosciences.
Valagro Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.45% increase. The company also saw a substantial fall in profitability, with a 16.25% decrease in profit. The company's net worth Soared by an impressive increase of 38.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valagro Biosciences?
In 2023, Valagro Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Mar 2019 | ₹19.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Apr 2013 | ₹4.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 28 Jan 2013 | ₹13.00 Cr | Satisfied |
How Many Employees Work at Valagro Biosciences?
Valagro Biosciences has a workforce of 288 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 18, 2020, Valagro Biosciences has raised a total of ₹ 287.76 Cr, with the most recent deal valued at ₹ 5.71 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
